28401
This review discusses current anticoagulation reversal recommendations for the oral anticoagulants warfarin , dabigatran , and rivaroxaban for patients at a heightened risk of bleeding , actively bleeding , or those in need of preprocedural anticoagulation reversal .
 warfarin, dabigatran, rivaroxaban
Please list all entity words in the text that fit the category. Output format is "word1, word2". 
Option: Chemical 
Text: {0} 
Answer:
 warfarin, dabigatran, rivaroxaban